The synthesized piperazium salt of KMUPS or KMUPS disclosed in the present invention is characterized by presented pharmaceutics having functions to improve 5-HT and eNOS activities of KMUPS in lung diseases, such as proliferation, obliteration, pulmonary artery hypertension.